The effects of atorvastatin on inflammatory responses and mortality in septic shock: A single-center, randomized controlled trial

Conclusions: Atorvastatin-induced changes in inflammatory biomarkers did not confer mortality benefit in septic shock (ClinicalTrials.govNCT02681653).

Source: Indian Journal of Critical Care Medicine - October 17, 2017 Category: Intensive Care Authors: Ratender Kumar Singh Vikas Agarwal Arvind Kumar Baronia Sudeep Kumar Banani Poddar Afzal Azim Source Type: research